Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05322876
Other study ID # HHFP-001
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 22, 2022
Est. completion date December 31, 2024

Study information

Verified date April 2024
Source Poudre Valley Health System
Contact Victoria M Bandera, MS
Phone 7329913081
Email victoria.bandera@uchealth.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the feasibility of a 6-month family-based community intervention to mitigate cardiovascular disease risk factors in Hispanic families in northern Colorado as measured through biometric screenings, body composition, physical activity, and health knowledge.


Description:

The current project aims to leverage the UCHealth Healthy Hearts Family Program to provide a free, non-insurance-based 1-year cardiovascular disease (CVD) prevention and wellness program to Hispanic Colorado families. This program includes an interactive educational class series, baseline and quarterly biometric screenings, and optional consultations with an Exercise Physiologist and a Dietitian. This program takes a novel approach to preventative care by incorporating the family unit with the intention of having the child be the agent of change. The long-term goals of this project are to significantly improve CVD risk factors among participating families and to disseminate study findings to inform developing and current outreach programs to offer effective CVD prevention programs for Hispanic citizens. This work may ultimately lead to more Hispanics being served through new or existing programs, therefore expanding important preventative community health interventions into this underserved population.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date December 31, 2024
Est. primary completion date December 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 13 Years and older
Eligibility Inclusion Criteria: - At least one member of the family unit self-identifies as Hispanic - At least 13 years of age Exclusion Criteria: - Unwilling to wear Fitbit devices daily for 6 months except when charging and sleeping - Cannot read or understand either English or Spanish - Cannot return to screening location to perform the minimum of the baseline, 3-month and 6-month follow-up screenings - Children or adolescents will be excluded from this project without a minimum of one accompanying parent or guardian

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Healthy Hearts Family Program
Participants will participate in a baseline health and knowledge screening, followed by a 6-week once-weekly class series, and 3- and 6-month follow-up health and knowledge screenings.

Locations

Country Name City State
United States Medical Center of the Rockies Loveland Colorado

Sponsors (2)

Lead Sponsor Collaborator
Poudre Valley Health System Fitbit LLC

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Efficacy of program through changes in physical health - Daily Steps Physical activity metrics (daily average steps per month) measured by Fitbit devices Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Primary Efficacy of program through changes in physical health - Physical Activity Physical activity metrics (daily minutes of light, moderate and vigorous activity per month) measured by Fitbit devices Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Primary Efficacy of program through changes in physical health - Blood Pressure Biometric variables (blood pressure in mmHg) Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Primary Efficacy of program through changes in physical health - Lab Value -Lipid Profile Biometric variables - lab values (lipid profile in mg/dL) measured through finger stick blood sampling Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Primary Efficacy of program through changes in physical health - Lab Value - Triglycerides Biometric variables - lab values ( triglycerides in mg/dL) measured through finger stick blood sampling Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Primary Efficacy of program through changes in physical health - Lab Value - Blood Glucose Biometric variables - lab values (blood glucose all in mg/dL) measured through finger stick blood sampling Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Primary Efficacy of program through changes in physical health - Waist Circumference Body composition (waist circumference in inches) Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Primary Efficacy of program through changes in physical health - Body Composition - Muscle Mass Body composition (muscle mass in pounds) measured with a Tanita MC980Uplus multi-frequency bio-electrical impedance analysis device. Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Primary Efficacy of program through changes in physical health - Body Composition - Fat Mass Body composition (fat-free mass in pounds) measured with a Tanita MC980Uplus multi-frequency bio-electrical impedance analysis device. Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Primary Efficacy of program through changes in physical health - Body Fat Percentage Body composition (body fat percentage) measured with a Tanita MC980Uplus multi-frequency bio-electrical impedance analysis device. Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Primary Efficacy of program through changes in physical health - Visceral Fat Rating Body composition (Tanita visceral fat rating) measured with a Tanita MC980Uplus multi-frequency bio-electrical impedance analysis device. Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Primary Efficacy of program through changes in health knowledge Health knowledge gained and retained will be evaluated and compared at baseline, post-6 week class series, 3- and 6-month follow-ups utilizing previously developed and utilized Healthy Hearts knowledge survey. This outcome will be measured by correct responses on the Healthy Hearts knowledge survey. Baseline, post-6 week class series, 3- and 6-month follow-up appointments.
Secondary Adherence to program and utilization of additional resources - Program attendance - Percentage of Scheduled Visits Attended Attendance for screenings, classes and other consultations across baseline and follow-up visits. Attendance will be measured as the percentage of scheduled visits (including the 6 week class series and the 3- and 6-month follow-up visits) completed. These variables will be measured and assessed throughout the full 6 month program.
Secondary Adherence to program and utilization of additional resources - Fitbit Utilization Compliance to Fitbit utilization as measured by days worn throughout the 6 month program. The NHANES compliance to wear time of > 10 hours worn per day will be utilized. These variables will be measured and assessed throughout the full 6 month program.
Secondary Adherence to program and utilization of additional resources - Resource Utilization Use of Exercise Physiologist and Dietician resources provided will be quantified and reported. This outcome will be reported as the number of consultation appointments requested and utilized throughout the program. These variables will be measured and assessed throughout the full 6 month program.
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Recruiting NCT04417387 - The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
Not yet recruiting NCT06211361 - Cardiac Rehabilitation Program in Patients With Cardiovascular Disease N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04514445 - The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT03273972 - INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers N/A
Completed NCT03680638 - The Effect of Antioxidants on Skin Blood Flow During Local Heating Phase 1
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Completed NCT04083846 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) Phase 1
Completed NCT04083872 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) Phase 1
Completed NCT03466333 - Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia Phase 2
Completed NCT03619148 - The Incidence of Respiratory Symptoms Associated With the Use of HFNO N/A
Completed NCT03693365 - Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT05132998 - Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)